Dr. TalÃa Malagón is an epidemiologist, mathematical modeller, and assistant professor in the Gerald Bronfman Department of Oncology at McGill University and at St Mary’s Research Centre. Her research projects include understanding the predictors of human papillomavirus transmission between sexual partners, risk factors for cervical precancer, and decision modeling to evaluate the balance of screening harms and benefits of cervical cancer screening, and health inequalities in cancer incidence and cancer care pathways. Dr. Malagón is a member of the McGill Department of Oncology COVID-19 and Cancer Program, whose goal is to generate evidence to assess the impact of the COVID-19 pandemic on cancer-related services across its network and inform decision-making for the resumption and improvement of cancer-related services.
Dr. Malagón has a B.Sc. in biology from the University of Ottawa (2010), and a Ph.D. in epidemiology from Université Laval (2016). She teaches graduate-level and resident courses in cancer epidemiology in the Departments of Oncology and the Department of Epidemiology, Biostatistics, and Occupational Health. She is a senior editor of Cancer Epidemiology, Biomarkers & Prevention (2022-), a reviewing editor at eLife (2020-), and a Board member of the International Papillomavirus Society. Her expertise includes using decision models, repeated and correlated events analyses, multilevel mixed effects modeling, generalized estimating equation, meta-regression models, multi-state Markov models, transmission dynamic models, and Bayesian analyses for answering causal questions in the fields of oncology and infectious diseases.
Dr. Malagón is currently recruiting for the following position: Postdoctoral researcher position in health decision modeling.
Contact Dr.ÌýMalagón:Ìý(514) 398-5984 or talia.malagon [at] mcgill.ca (by email).Ìý
Ìý
EDUCATION
PhD in Epidemiology |
2010-2016 |
Honours B.Sc. with Specialization in Biology (Ecology, Evolution, Behaviour) |
2006-2010 |